The FDA rejected Cingulate Inc.'s ADHD medicine application over manufacturing issues. Cingulate holds nearly $30 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results